Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease
Completed · Phase 2 · Has a placebo group
Conditions studied: Elevated Lipoprotein(a), Cardiovascular Disease
In brief
This is a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the safety, including tolerability, of ISIS 681257 and to assess the efficacy of different doses and dosing regimens of ISIS 681257 for reduction of plasma Lipoprotein(a) \[Lp(a)\] levels in participants with hyperlipoproteinemia(a) and established cardiovascular disease (CVD).
Key facts
- Study ID
- NCT03070782
- Run by
- Akcea Therapeutics
- People needed
- 286
- Starts
- 2017-03-07
- Expected to finish
- 2018-11-13
- Last updated by the study team
- 2020-10-30
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clinical Site — Cottonwood, Arizona, United States
- Clinical Site — Huntington Beach, California, United States
- Clinical Site — La Jolla, California, United States
- Clinical Site — Los Angeles, California, United States
- Clinical Site — Stanford, California, United States
- Clinical Site — Colorado Springs, Colorado, United States
- Clinical Site — Boca Raton, Florida, United States
- Clinical Site — Jacksonville, Florida, United States
- Clinical Site — Kansas City, Kansas, United States
- Clinical Site — Baltimore, Maryland, United States
- Clinical Site — Boston, Massachusetts, United States
- Clinical Site — Cooperstown, New York, United States
- Clinical Site — New York, New York, United States
- Clinical Site — New York, New York, United States
- Clinical Site — Cleveland, Ohio, United States
- Clinical Site — Portland, Oregon, United States
- Clinical Site — Lancaster, Pennsylvania, United States
- Clinical Site — Philadelphia, Pennsylvania, United States
- Clinical Site — Providence, Rhode Island, United States
- Clinical Site — Houston, Texas, United States
- Clinical Site — Falls Church, Virginia, United States
- Clinical Site — Milwaukee, Wisconsin, United States
- Clinical Site — Chicoutimi, Quebec, Canada
- Clinical Site — Montreal, Quebec, Canada
- Clinical Site — Montreal, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.